SCOTTSDALE, ARIZONA -- (MARKET WIRE) -- December 04, 2006 -- Holmes Biopharma, Inc. (PINK SHEETS: HLMB) announced it has commenced a strategy of acquiring several additional clinical research facilities in the coming months. The focus will be on profitable businesses with proven track records; that compliment the Company's current operations.
